◄ back to all posts

RIOT: Riot Blockchain Inc Stock

Written by | Jul, 6, 2018

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 31.91
Enterprise Value ($M) 30.66
Book Value ($M) -7.25
Book Value / Share -0.49
Price / Book -4.58
NCAV ($M) -21.32
NCAV / Share -1.44
Price / NCAV -1.56

Profitability (mra)
Return on Invested Capital (ROIC) -10.40
Return on Assets (ROA) -1.15
Return on Equity (ROE) -1.23

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 0.13

Balance Sheet (mrq) ($M)
Current Assets 2.89
Assets 15.45
Liabilities 24.22
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.85
Operating Income -59.37
Net Income -60.21
Earnings Per Share Basic And Diluted -4.33

Cash Flow Statement (mra) ($M)
Cash From Operations -19.05
Cash from Investing -24.86
Cash from Financing -24.86

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2019-04-18 13G Calc Iii Lp 4.40
2019-02-14 13G/A Susquehanna Securities 3.00
2019-01-31 13G/A Hudson Bay Capital Management LP 2.25

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

Similar Companies
RGLS – Regulus Therapeutics Inc. RGNX – REGENXBIO Inc.
RIGL – Rigel Pharmaceuticals, Inc. RLYP – Relypsa, Inc.
RPGN – REPLIGEN CORP


Financial data and stock pages provided for FREE by
Fintel.io




2018/07/06
◄ back to all posts
Retirement